Could a simple timing change protect transplant patients?
NCT ID NCT06294678
Summary
This study is testing whether the time of day a patient receives donor stem cells can reduce the risk of a dangerous immune reaction called acute graft-versus-host disease (GVHD). It involves about 200 people with blood cancers who are getting a stem cell transplant. Researchers are comparing outcomes for patients who get their stem cell infusion at different times to see if timing helps prevent this serious complication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-GRAFT-VERSUS-HOST DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100000, China
-
Rui Jin Hospital Affiliated to Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, 200000, China
-
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Hefei, Anhui, 230036, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450000, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.